Skip to main content

Are In Vitro Metabolism and DDI Studies Critical for an IND?

Thank you

This live web event has ended. Thank you for attending.

Contributors

  • Andrew Taylor, Ph.D.

    Andrew G. Taylor received his Ph.D. from University of California San Diego. He joined SEKISUI XenoTech as a research scientist in 2017, serving as a Study Director in nonclinical drug interaction contract studies in compliance with Good Laboratory Practices (GLP), OECD Principles of GLP, &/or Japan MOHW GLP Standards and specializing in drug transport and drug metabolism studies. He became the Technical Support Manager for services in 2020 and provides valuable guidance to ensure research needs are being met.

January 27, 2022
Thu 12:30 PM EST

Duration 1H 30M

This live web event has ended.

For Technical Support
(888) 705-6002
+1 (858) 201-4136*
*for callers residing outside of the United States